Creative Biolabs highlights the growing importance of antibody engineering and conversion strategies in advancing ...

The US National Science Foundation (NSF) has launched an investment programme to advance scientific community datasets and ...

An essential component of this technological rollout is the AI-driven de novo antibody sequence generation service. This ...

The deadline for abstract submission (late-breaking posters) is coming up on 30 th July. The deadline for late registration ...

Chai Discovery, an AI company developing a computer-aided design suite for molecules, is collaborating with Novartis to advance the discovery of therapeutic antibodies using AI Under the collaboration ...

Beckman Coulter Diagnostics, a specialist in clinical diagnostics and a Danaher company, has received CE Mark under IVDR for its Acess p-Tau217 assay, a blood test designed to support the clinical ...

Seegene has launched the Global Million Clinical Study (GMCS), aiming to evaluate the clinical utility and potential impact of comprehensive syndromic PCR testing approaches using real-world data The ...

AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on native Outer Membrane Vesicles (nOMVs), has published first-in-human Phase I clinical data ...

TNF superfamily (TNFSF) proteins are key regulators of immune homeostasis and inflammation. Many TNFSF proteins naturally assemble as homotrimers, a structural feature that is critical for receptor ...

Some diseases are more unkind than others. Cystic fibrosis, an inherited disorder often inflicting the young, causes severe damage to the lungs, digestive system and other organs in the body (Clinic, ...

Tau is a microtubule‑associated protein with N‑terminal, proline‑rich, microtubule‑binding, and C‑terminal domains, where the microtubule‑binding region mediates microtubule interaction; alternative ...

AbbVie has shared its topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell-engaging bispecific antibody, and lenalidomide, compared to rituximab ...